Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-18-000033

Sr. VP & Chief Medical Officer sold 4,155 shares at an average $92.32 ($383,596)

  • Sr. VP & Chief Medical Officer acquired 2,955 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Adda Nathalie · Sr. VP & Chief Medical Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2018-08-20 Exercise or conversion : show line 1 in the form +2,955 $43.46 $128,424 4,465 D
2018-08-20 Sale : show line 2 in the form −572 $90.58 $51,812 3,893 D
2018-08-20 Sale : show line 3 in the form −700 $91.49 $64,042 3,193 D
2018-08-20 Sale : show line 4 in the form −2,224 $92.68 $206,130 969 D
2018-08-20 Sale : show line 5 in the form −659 $93.49 $61,613 310 D
Open-market sales · 4,155 sh · avg $92.32 · $383,596

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-08-20 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −2,955 $43.46 2025-06-29 2,955 75,225 D
Loading xslF345X03/edgar.xml…